ArticleThe Journal of investigative dermatology2015

Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma.

C Posch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.